Kolexia
Pigeyre Marie
Endocrinologie
Centre Hospitalier de Lille
Lille, France
144 Activités
220 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Obésité Diabète Diabète de type 2 Obésité morbide Perte de poids Prédisposition génétique à une maladie Complications du diabète Intolérance au glucose Maladie des artères coronaires

Industries

Lilly
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study.
European heart journal   01 mars 2024
A method to estimate the contribution of rare coding variants to complex trait heritability.
Nature communications   09 février 2024
Impact of Covid-19 lockdown on occurrence of acute diabetes complications and overall glycemic control.
Canadian journal of diabetes   11 décembre 2023
Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk.
Diabetes care   06 décembre 2023
A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation.
Kidney international   27 septembre 2023
Surrogate Adiposity Markers and Mortality.
JAMA network open   05 septembre 2023
Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk: A 2-Sample Mendelian Randomization Study.
JAMA network open   03 juillet 2023
Fine-mapping of retinal vascular complexity loci identifies Notch regulation as a shared mechanism with myocardial infarction outcomes.
Communications biology   15 mai 2023
Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial.
Diabetologia   01 mars 2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
Clinical journal of the American Society of Nephrology : CJASN   07 février 2023